• 484 Citations
  • 10 h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Radhashree Maitra is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications

  • 484 Citations
  • 10 h-Index
  • 18 Article
  • 2 Review article

Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS-Mutated Colorectal Cancer

Goel, S., Ocean, A. J., Parakrama, R. Y., Ghalib, M. H., Chaudhary, I., Shah, U., Viswanathan, S., Kharkwal, H., Coffey, M. & Maitra, R., May 1 2020, In : Molecular cancer therapeutics. 19, 5, p. 1148-1156 9 p.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    Immune characterization of metastatic colorectal cancer patients post reovirus administration

    Parakrama, R., Fogel, E., Chandy, C., Augustine, T., Coffey, M., Tesfa, L., Goel, S., Goel, S., Maitra, R., Maitra, R. & Maitra, R., Jun 18 2020, In : BMC Cancer. 20, 1, 569.

    Research output: Contribution to journalArticle

    Open Access
  • Protein arginine methyltransferase 5 as a therapeutic target for kras mutated colorectal cancer

    Shifteh, D., Sapir, T., Pahmer, M., Haimowitz, A., Goel, S. & Maitra, R., Aug 2020, In : Cancers. 12, 8, p. 1-17 17 p., 2091.

    Research output: Contribution to journalArticle

    Open Access
  • Development and characterization of a genetic mouse model of KRAS mutated colorectal cancer

    Maitra, R., Thavornwatanayong, T., Venkatesh, M. K., Chandy, C., Vachss, D., Augustine, T., Guzik, H., Koba, W., Liu, Q. & Goel, S., Nov 2 2019, In : International Journal of Molecular Sciences. 20, 22, 5677.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin

    Rao, D., Mallick, A. B., Augustine, T., Daroqui, C., Jiffry, J., Merla, A., Chaudhary, I., Seetharam, R., Sood, A., Gajavelli, S., Aparo, S., Rajdev, L., Kaubisch, A., Chuy, J., Negassa, A., Mariadason, J. M., Maitra, R. & Goel, S., 2019, In : Oncotarget. 10, 53, p. 5510-5522 13 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations